1. Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2017.78
Figure 1 Timeline depicting the development of clinicopathological classifications,
staging, and response assessment guidelines, and radiographic techniques in lymphoma
Figure 1 | Timeline depicting the development of clinicopathological classifications, staging, and response assessment guidelines, and radiographic techniques in lymphoma. Developments in pathological classification systems are shown in beige, developments in clinical or radiological classification systems are shown in blue, and developments in imaging technologies are shown in orange. Abbreviations: DLBCL, diffuse, large-B-cell lymphoma; FDG, fluorodeoxyglucose; IWG, International Working Group; LyRIC, Lymphoma Response to Immunomodulatory Therapy Criteria; MRI, magnetic resonance imaging; NHL, non-Hodgkin lymphoma; PET, positron-emission tomography; PETT, positron-emission transaxial tomography; REAL, revised European-American classification of lymphoid neoplasms; RECIL, Response Evaluation Criteria in Lymphoma; SUV, standard uptake value. *Denotes further discussion within article. Three categories within 'timeline': development in imaging technology, pathology classification system, clinical or radiological classification/staging system.
Cunningham, J. et al. (2017) Evolution of lymphoma staging and response evaluation: current limitations and future directions
Nat. Rev. Clin. Oncol. doi: /nrclinonc